Regeneron Pharmaceuticals | REGN - Debt

Stock Price
771.94
Daily Change
-15.10 -1.92%
Monthly
1.22%
Yearly
6.70%
Q1 Forecast
755.50

Regeneron Pharmaceuticals reported $2.71B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Agenus USD 35.54M 2.34M Mar/2025
Agios Pharmaceuticals USD 44.52M 4.24M Sep/2025
Alnylam Pharmaceuticals USD 1.31B 11.39M Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
Astellas Pharma JPY 831.43B 83.94B Mar/2025
AstraZeneca USD 32.63B 207M Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
BioMarin Pharmaceutical USD 604.24M 375K Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Incyte USD 40.41M 855K Dec/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Kyowa Hakko Kirin JPY 28.75B 5.04B Dec/2024
Merck USD 41.37B 5.97B Sep/2025
Moderna USD 734M 7M Sep/2025
Neurocrine Biosciences USD 428.4M 10.7M Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novartis USD 32.02B 615M Sep/2025
Pfizer USD 60.85B 78M Sep/2025
Puma Biotechnology USD 89.06M 55.07M Jun/2024
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025
Ultragenyx Pharmaceutical USD 33.83M 2.46M Sep/2025
United Therapeutics USD 200M 100M Mar/2025
Vertex Pharmaceuticals USD 1.83B 307.4M Sep/2025